Previous SARS-CoV-2 infection, age, and frailty are associated with 6-month vaccine-induced anti-spike antibody titer in nursing home residents

AH Dyer, C Noonan, M McElheron, I Batten… - Journal of the American …, 2022 - Elsevier
Objectives Older nursing home residents make up the population at greatest risk of morbidity
and mortality from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …

Persistence and protective potential of SARS-CoV-2 antibody levels after COVID-19 vaccination in a West Virginia nursing home cohort

K Smoot, J Yang, DH Tacker, S Welch… - JAMA Network …, 2022 - jamanetwork.com
Importance West Virginia prioritized SARS-CoV-2 vaccine delivery to nursing home facilities
because of increased risk of severe illness in elderly populations. However, the persistence …

Strong decay of SARS-CoV-2 spike antibodies after 2 BNT162b2 vaccine doses and high antibody response to a third dose in nursing home residents

H Blain, E Tuaillon, L Gamon, A Pisoni, S Miot… - Journal of the American …, 2022 - Elsevier
Objectives To measure the antibody decay after 2 BNT162b2 doses and the antibody
response after a third vaccine dose administered 6 months after the second one in nursing …

Pronounced antibody elevation after SARS‐CoV‐2 BNT162b2 mRNA booster vaccination in nursing home residents

Y Chong, T Goto, N Tani, A Yonekawa… - Influenza and Other …, 2022 - Wiley Online Library
Background Infection control during COVID‐19 outbreaks in nursing facilities is a critical
public health issue. Antibody responses before and after the third (booster) dose of SARS …

[HTML][HTML] Significantly elevated antibody levels and neutralization titers in nursing home residents after SARS-CoV-2 BNT162b2 mRNA booster vaccination

DH Canaday, OA Oyebanji, E White, D Keresztesy… - MedRxiv, 2021 - ncbi.nlm.nih.gov
Nursing home (NH) residents have experienced significant morbidity and mortality to SARS-
CoV-2 throughout the pandemic. Vaccines initially curbed NH resident morbidity and …

[HTML][HTML] T-cell mediated response after primary and booster SARS-CoV-2 messenger RNA vaccination in nursing home residents

I Schiavoni, A Palmieri, E Olivetta, P Leone… - Journal of the American …, 2023 - Elsevier
Objectives Nursing home (NH) residents have been significantly affected by the coronavirus
disease 2019 (COVID-19) pandemic. Studies addressing the immune responses induced by …

[HTML][HTML] Weak humoral immune reactivity among residents of long-term care facilities following one dose of the BNT162b2 mRNA COVID-19 vaccine

MA Brockman, F Mwimanzi, Y Sang, K Ng, O Agafitei… - medRxiv, 2021 - ncbi.nlm.nih.gov
Background. Several Canadian provinces are extending the interval between COVID-19
vaccine doses to increase population vaccine coverage more rapidly. However …

Anti‐spike IgG antibody kinetics following the second and third doses of BNT162b2 vaccine in nursing home residents

H Jeulin, C Labat, K Duarte, S Toupance… - Journal of the …, 2022 - Wiley Online Library
Background Duration of post‐vaccination protection against COVID‐19 in nursing home
(NH) residents is a critical issue. The objective of this study was to estimate the duration of …

Persistence of anti-SARS-CoV-2 antibodies in long term care residents over seven months after two COVID-19 outbreaks

G Tanunliong, A Liu, R Vijh, T Pidduck… - Frontiers in …, 2022 - frontiersin.org
Background As part of the public health outbreak investigations, serological surveys were
carried out following two COVID-19 outbreaks in April 2020 and October 2020 in one long …

Antibody responses after mRNA-based COVID-19 vaccination in residential older adults: implications for reopening

DA Nace, KE Kip, JW Mellors, OMP Palmer… - Journal of the American …, 2021 - Elsevier
Objective COVID-19 disproportionately impacts residents in long-term care facilities. Our
objective was to quantify the presence and magnitude of antibody response in vaccinated …